Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
about
Exploring public genomics data for population pharmacogenomicsMedical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).Clinical and educational impact of pharmacogenomics testing: a case series from the INGENIOUS trial.Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.Genetic variation in human drug-related genes.Advanced bioanalytics for precision medicine.Pharmacogenetics: a general review on progress to date.Pharmacogenomics: Precision Medicine and Drug Response.Biomarkers of adverse drug reactions.The challenges of implementing pharmacogenomic testing in the clinic.Benefit of pre-emptive pharmacogenetic information on clinical outcome.Research directions in the clinical implementation of pharmacogenomics - An Overview of US programs and projects.Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project.Precision Medicine-Nobody Is Average.An opportunity for clinical pharmacology trained physicians to improve patient drug safety: A retrospective analysis of adverse drug reactions in teenagersNetwork, Transcriptomic and Genomic Features Differentiate Genes Relevant for Drug ResponseUser considerations in assessing pharmacogenomic tests and their clinical support tools
P2860
Q38644432-6C310567-213D-45E7-A138-AC50237F9370Q38663993-380DEE72-7E23-47B0-BD73-9930B71D4F04Q39359362-A0487F84-7B70-4821-B942-8364E5A4A52CQ46776696-794827F4-384B-4809-AF5B-0C229F225100Q47564586-F93C9738-F9C7-4AFE-9DC6-D2C21F6741C6Q47656712-66BC2181-066F-4831-AECC-8FEEB9D1D49EQ47776901-A4BCD33C-ADCC-433C-8313-C2FFC3DE92F3Q47860317-186D1870-BAF6-443E-82D1-8285011EFD84Q47928481-71222C14-78B0-4625-BB49-03C18034784BQ47929031-C0DC53F9-E3F3-49EB-81CE-1BC211F11376Q49612005-FEA58D43-6C42-4E9D-9F0A-DC255CC4948DQ49822573-7E5BD095-DAED-4508-B71C-E238AC43776CQ49999241-757E4ACA-4231-4FC4-BA0F-A3AA7506C06CQ53508013-B1D8BDDE-6215-42D3-94D2-93116D0D696AQ57144915-2F1D00F9-AAF7-4BEC-B087-9AD08643B08AQ57491987-C79D88A3-D6BA-4BD6-A37D-02C39BEF2E74Q57646588-883ED07C-2E16-4CF3-BFCD-E2B6FAD9CE8B
P2860
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Implementing Pharmacogenomics ...... s Pharmacogenomics Consortium.
@en
Implementing Pharmacogenomics ...... s Pharmacogenomics Consortium.
@nl
type
label
Implementing Pharmacogenomics ...... s Pharmacogenomics Consortium.
@en
Implementing Pharmacogenomics ...... s Pharmacogenomics Consortium.
@nl
prefLabel
Implementing Pharmacogenomics ...... s Pharmacogenomics Consortium.
@en
Implementing Pharmacogenomics ...... s Pharmacogenomics Consortium.
@nl
P2093
P2860
P50
P356
P1476
Implementing Pharmacogenomics ...... us Pharmacogenomics Consortium
@en
P2093
A Cambon-Thomsen
C H van der Wouden
C L Dávila-Fajardo
C Mitropoulou
D Steinberger
E Schaeffeler
G P Patrinos
K C Cheung
M H van Rhenen
M Ingelman-Sundberg
P2860
P304
P356
10.1002/CPT.602
P407
P50
P577
2017-03-01T00:00:00Z